Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) - Related Studies

Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)

This study has been completed.

Study NCT00000518. Last updated on June 23, 2005. Information provided by National Heart, Lung, and Blood Institute (NHLBI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Arrhythmia
		Cardiovascular Diseases
		Death, Sudden, Cardiac
		Heart Diseases
		Tachycardia, Ventricular
		Ventricular Arrhythmia
		Ventricular Fibrillation

2	Additional conditions recognized in this trial
		Arrhythmias, Cardiac
		Death, Sudden
		Tachycardia

3	More general conditions related to this trial
		Death
		Heart Arrest
		Pathologic Processes

4	Interventions listed in this trial
		electrophysiology
		electrocardiography, ambulatory
		imipramine
		mexiletine
		procainamide
		quinidine
		sotalol

5	More general drug interventions related to this trial
		Adrenergic Agents
		Adrenergic alpha-Antagonists
		Adrenergic Antagonists
		Adrenergic Uptake Inhibitors
		Anti-Arrhythmia Agents
		Anti-Infective Agents
		Antidepressive Agents
		Antidepressive Agents, Tricyclic
		Antimalarials
		Antiparasitic Agents
		Antiprotozoal Agents
		Cardiovascular Agents
		Central Nervous System Agents
		Cholinergic Agents
		Cholinergic Antagonists
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Muscarinic Antagonists
		Neurotransmitter Agents
		Neurotransmitter Uptake Inhibitors
		Pharmacologic Actions
		Physiological Effects of Drugs
		Psychotropic Drugs
		Therapeutic Uses

6	Sponsors listed in this trial
		National Heart, Lung, and Blood Institute (NHLBI)